ai
AI innovation for personalized immunotherapy for Cancer Patients
NormaxAI Inc. is a C-corporation in Delaware USA specializing in AI innovation for personalized medicine with integrated hardware and software solutions.
What we Do
Our Mission
At NormaxAI, we are committed to helping cancer patients with personalized immunotherapy [n=1] by leveraging the power of safe artificial intelligence (AI).
AI ASSISTED IMMUNOTHERAPY
Advanced AI tools enable the analysis of genomic sequences of the patient’s normal and cancer tissues for automated identification of neoantigen targets for the patient’s specific cancer.
CONFIDENTIAL COMPUTING
NormaxAI data handling procedures are in compliance with U.S. Health Insurance Portability and Accountability Act of 1996 (HIPAA) and E.U. General Data Protection Regulation (GDPR).
REGULATORY COMPLIANCE
NormaxAI is applying for a license with MTIF under the “specials” program of the The Medicines and Healthcare products Regulatory Agency of the UK.
MEDICAL CHAT-BOT
For Doctors & Patients
Educated Antigen Receptor Therapy (EARTh) GMP Process is under deployment at MTIF GMP Clean Room in cooperation with BiocommAI and Google Cloud/Google Deepmind and Thermo Fisher Nucleic Acid Therapeutics Group.
SCIENTIFIC CHAT-BOT
For Doctors and Patients
The first Virtual Tumor Board by NormaxAI is under deployment at MTIF-NTU in cooperation with BiocommAI.
BiocommAI Partnership
At BiocommAI, we are committed to innovation in the healthcare industry by leveraging the power of safe artificial intelligence (AI).
Join un in the future of AI empowered healthcare.
Contact
info@nrvx.net